|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
MARAVIROC |
J05AX09 |
IT
|
I
|
|
None |
|
VALID
|
|
MARIBAVIR |
J05AX10 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
LETERMOVIR |
J05AX18 |
IT
|
I
|
|
EMEA/H/C/004536 |
08-01-2018 |
VALID
|
|
IBALIZUMAB |
J05AX23 |
IT
|
I
|
|
|
|
VALID
|
|
TECOVIRIMAT |
J05AX24 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
BALOXAVIR MARBOXIL |
J05AX25 |
IT
|
Not authorised
|
|
|
|
VALID
|
|
BULEVIRTIDE |
J05AX28 |
IT
|
I
|
22-12-2020 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
LENACAPAVIR |
J05AX31 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASCULAR ADM. |
J06BA01 |
IT
|
I
|
|
|
|
VALID
|
|
IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM. |
J06BA02 |
IT
|
I
|
|
|
|
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005169 |
18-11-2020 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
CHOLERA, LIVE ATTENUATED |
J07AE02 |
IT
|
I
|
|
|
|
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN |
J07BB02 |
IT
|
I
|
07-05-2019 |
EMEA/H/C/004814 |
12-12-2018 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
EBOLA VACCINES |
J07BX02 |
IT
|
I
|
05-06-2020 |
EMEA/H/C/004554 |
11-11-2019 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
IT
|
I
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
CHLORAMBUCIL |
L01AA02 |
IT
|
I
|
|
|
|
VALID
|
|
MELPHALAN |
L01AA03 |
IT
|
I
|
|
|
|
VALID
|
|
CHLORMETHINE |
L01AA05 |
IT
|
Not authorised
|
18-08-2017 |
|
|
VALID
|
|
BENDAMUSTINE |
L01AA09 |
IT
|
I
|
|
None |
|
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
TREOSULFAN |
L01AB02 |
IT
|
I
|
28-11-2019 |
EMEA/H/C/004751 |
19-06-2019 |
VALID
|
|
CARMUSTINE |
L01AD01 |
IT
|
I
|
|
|
|
VALID
|
|
FOTEMUSTINE |
L01AD05 |
IT
|
I
|
|
|
|
VALID
|
|
PIPOBROMAN |
L01AX02 |
IT
|
II
|
|
None |
16-09-2003 |
VALID
|
|
TEMOZOLOMIDE |
L01AX03 |
IT
|
I
|
|
|
|
VALID
|
|
DACARBAZINE |
L01AX04 |
IT
|
I
|
|
|
|
VALID
|
|
METHOTREXATE |
L01BA01 |
IT
|
I
|
23-01-2019 |
|
|
VALID
|
|
RALTITREXED |
L01BA03 |
IT
|
I
|
|
None |
16-09-2003 |
VALID
|
|
PEMETREXED |
L01BA04 |
IT
|
I
|
|
None |
|
VALID
|
|
TIOGUANINE |
L01BB03 |
IT
|
I
|
|
|
|
VALID
|
|
CLADRIBINE |
L01BB04 |
IT
|
I
|
|
|
|
VALID
|
|
FLUDARABINE |
L01BB05 |
IT
|
I
|
|
None |
|
VALID
|
|
CLOFARABINE |
L01BB06 |
IT
|
I
|
|
None |
|
VALID
|
|
NELARABINE |
L01BB07 |
IT
|
I
|
|
None |
|
VALID
|
|
FLUOROURACIL |
L01BC02 |
IT
|
I
|
|
|
|
VALID
|
|
TEGAFUR |
L01BC03 |
IT
|
Not authorised
|
|
|
|
VALID
|
|
GEMCITABINE |
L01BC05 |
IT
|
I
|
|
IT/H/0171/002/DC |
08-10-2009 |
VALID
|
|
CAPECITABINE |
L01BC06 |
IT
|
I
|
|
|
|
VALID
|
